文献速递中毒与环境急症消化、代谢与肾脏急症

海洛因过量患者使用纳洛酮后是否需要观察?

Do heroin overdose patients require observation after receiving naloxone?
PubMed 文献 · Clin Toxicol (Phila) · 2016-11-16
一句话结论海洛因过量经纳洛酮复苏后,若意识与生命体征正常可安全不予转运;急诊观察1小时、能正常行走、生命体征正常且GCS 15分即可出院。

本文通过检索PubMed与GoogleScholar(截至2016年9月31日),综述海洛因过量使用纳洛酮后的三个问题:拒绝救护车转运的医学风险、急诊观察时长、急救人员与旁观者使用纳洛酮的有效性与安全性。8项观察性研究显示,5443例未转运患者中4例死于反跳性阿片毒性,需转运挽救1例生命的NNT为1361;5项研究涉及急诊观察时长,其中1项支持观察1小时。15篇文献显示旁观者/急救人员使用纳洛酮生存率100%(11项研究)及96-99%(4项研究),培训项目风险很少。结论认为意识与生命体征正常者可安全不予转运,急诊观察1小时足够。

要点

  • 海洛因过量经纳洛酮复苏后,若意识与生命体征正常,可安全不予救护车转运(作者结论)。
  • 5443例未转运患者中4例死于反跳性阿片毒性,需转运挽救1例生命的NNT为1361。
  • 急诊使用纳洛酮治疗阿片过量后,观察1小时;若患者能正常行走、生命体征正常且GCS 15分,可安全出院。
  • 旁观者与急救人员使用纳洛酮:系统评价中11项研究生存率100%,其余4项生存率96-99%;另2项随访差的研究成功率83%与89%。
  • 培训普通人使用纳洛酮的阿片过量预防项目风险很少,可能安全且有益,但需进一步研究。

适用人群与场景

  • 海洛因过量使用纳洛酮后拒绝救护车转运的患者。
  • 急诊科接受纳洛酮治疗的阿片类药物过量患者。
  • 接受急救人员或旁观者使用纳洛酮的阿片类药物过量患者。

诊断标准与关键阈值

  • 急诊出院标准:观察1小时后能正常行走、生命体征正常且Glasgow昏迷评分15分。

处置流程与药物剂量

  • 海洛因过量经纳洛酮复苏后,若意识与生命体征正常,可安全不予转运至医院(作者结论)。
  • 急诊使用纳洛酮治疗阿片过量后观察1小时;若患者能正常行走、生命体征正常且GCS 15分,可安全出院。
  • 急救人员与受过培训的普通人可安全给予纳洛酮。

红旗征与不能漏的情况

  • 反跳性阿片毒性:5443例未转运患者中4例死亡。
  • 合并其他中毒物质及继续使用阿片类药物时,反跳性阿片毒性死亡风险极低的前提不成立。

研究设计与关键结果

  • 检索PubMed与GoogleScholar(截至2016年9月31日),1020篇文献中8篇涉及前两个问题,707篇中5篇涉及第三个问题,287篇中15篇涉及第四个问题。
  • 8项观察性研究(前瞻性或回顾性)中,2项聚焦海洛因过量、纳入1069例未转运患者,无死亡;全部8项合计5443例未转运患者中4例死于反跳性阿片毒性,需转运挽救1例生命的NNT为1361,不良事件多与阿片戒断相关。
  • 5篇涉及急诊观察时长的文献报告范围较广,其中1项研究支持观察1小时。
  • 15篇相关文献中,系统评价报告11项研究生存率100%,其余4项生存率96-99%;另2项研究随访差,成功率分别为83%与89%。
  • 培训普通人使用纳洛酮的阿片过量预防项目风险很少。

证据类型、等级与局限

  • 证据类型:综述,纳入观察性研究(前瞻性或回顾性)及系统评价。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,海洛因过量经纳洛酮复苏后意识与生命体征正常者可安全不予转运至医院。
  • 作者认为,急诊阿片过量患者观察1小时、能正常行走、生命体征正常且GCS 15分即可安全出院。
  • 作者认为,急救人员与受过培训的普通人可安全给予纳洛酮,培训项目可能安全且有益,但需进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

CONTEXT: Heroin use in the US has exploded in recent years, and heroin overdoses requiring naloxone are very common. After awakening, some heroin users refuse further treatment or transport to the hospital. These patients may be at risk for recurrent respiratory depression or pulmonary edema. In those transported to the emergency department, the duration of the observation period is controversial. Additionally, non-medical first responders and lay bystanders can administer naloxone for heroin and opioid overdoses. There are concerns about the outcomes and safety of this practice as well.

OBJECTIVES: To search the medical literature related to the following questions: (1) What are the medical risks to a heroin user who refuses ambulance transport after naloxone? (2) If the heroin user is treated in the emergency department with naloxone, how long must they be observed prior to discharge? (3) How effective in heroin users is naloxone administered by first responders and bystanders? Are there risks associated with naloxone distribution programs?

METHODS: We searched PubMed and GoogleScholar with search terms related to each of the questions listed above. The search was limited to English language and excluded patents and citations. The search was last updated on September 31, 2016. The articles found were reviewed for relevance to our objective questions. Eight out of 1020 citations were relevant to the first 2 questions, 5 of 707 were relevant to the third question and 15 of 287 were relevant to the fourth question. In the prehospital environment, does a heroin user revived with naloxone always require ambulance transport and what are the medical risks if ambulance transport is refused after naloxone? The eight articles were all observational studies done either prospectively or retrospectively. Two studies focused on heroin overdoses and included 1069 patients not transported to the hospital. No deaths occurred in this group. In counting the patients from all eight studies, some of which included non-heroin opioid overdoses, there were 5443 patients treated without transport and four deaths from rebound opioid toxicity. The number needed to transport to save one life (NNT) is 1361. Adverse effects were mostly related to opioid withdrawal. If a heroin user is treated in the ED, how long must the patient stay under observation before being safe for discharge? Five articles addressing the duration of ED observation required for patients treated with naloxone for opioid overdoses. Although a wide range of observation durations were reported, one study supported observing patients for one hour. If after this period the patient mobilizes as usual, has normal vital signs, and a Glasgow Coma Scale of 15, they can be discharged safely. What are the likely risks in heroin users following naloxone use by lay bystanders or first responders? Of the 15 relevant papers, a systematic review reported a 100% survival rate in eleven studies and a range of 96-99% survival in the remaining four. Two other studies suffered from poor follow-up and had lower success rates of 83% and 89%. Few if any risks were associated with opioid overdose prevention programs in which lay people were trained to administer naloxone.

CONCLUSIONS: Patients revived with naloxone after heroin overdose may be safely released without transport to the hospital if they have normal mentation and vital signs. In the absence of co-intoxicants and further opioid use there is very low risk of death from rebound opioid toxicity. For those patients treated in the ED for opioid overdose, an observation period of one hour is sufficient if they ambulate as usual, have normal vital signs and a Glasgow Coma Scale of 15. Patients suffering opioid toxicity can be administered naloxone safely by first responders and trained lay people. Programs that train these individuals are likely safe and beneficial, however further research is necessary.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Willman MW, Liss DB, Schwarz ES, et al. Do heroin overdose patients require observation after receiving naloxone? Clin Toxicol (Phila). 2016. PMID: 27849133. doi:10.1080/15563650.2016.1253846

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。